top of page

5TH ANNUAL BREAST CANCER SYMPOSIUM
DISPARITIES ON A CELLULAR LEVEL AND PATIENT LEVEL

COMMUNITY-BASED CANCER CARE AFFILIATE:

NYOH_MAIN_COLOR_LG.png

An Overview of Clinical Data for ENHERTU (fam-trastuzumab deruxtecan-nxki) in HER2-Expressing Metastatic Breast Cancer

unnamed-2.jpg
unnamed.jpg

Please join us for an informative, expert-led discussion presented by Daiichi Sankyo, Inc. and AstraZeneca to explore the data on the efficacy and safety of ENHERTU.

​

Provided by: Daiichi Sankyo Inc. and AstraZeneca

Quest Speaker: Francis Arena, MD

Affiliations: NYU Langone Arena Oncology

bottom of page